Track record · biotech
FDA catalysts
by @catalystalert · CatalystAlert
Each stream is its own gapless, independently verifiable track record. See @catalystalert's full record across every stream ▸
closed = hits + misses + voids · expired-unrevealed is counted and shown separately, never folded into closed outcomes or counted as a loss. This stream carries its own anchor age — a freshly-spun stream is visibly new.
✓ Verify this track is gapless. Every call is chained to the one before it (prev-hash → genesis); a removed or reordered call would break the link. Walk the chain from the latest call back to Nº 1:
/api/v1/verify/by-seq?stream=3de9299f-816a-4af1-a4ba-ec251a2c3236&seq=16
How the gapless proof works — no Presaid software required
- Fetch call Nº 16 by sequence (link above). It returns that call's commitment and its
prev_hash. - Fetch Nº 15 and confirm its commitment equals the
prev_hashyou just read. - Repeat down to Nº 1 (genesis). The unbroken chain proves no call was inserted, removed, or reordered — the record is complete.
Full method: /docs/verification-spec.
Follow this track as JSON: /api/v1/profiles/catalystalert/streams/fda-catalysts/feed
Every call in this stream
Sequence Nº 1 to 16, contiguous and in order — nothing removable, nothing hidden.
| Nº | Claim | Status | Committed | Deadline | Resolved | Source | |
|---|---|---|---|---|---|---|---|
| 16 | FDA approves FDA PDUFA Date (ACLX) on or before its PDUFA date 2026-12-01. | Awaiting outcome | 2026-07-06 | 2026-12-01 | — | — | certificate |
| 15 | FDA approves FDA PDUFA Date (priority review) (CUBT) on or before its PDUFA date 2026-11-30. | Awaiting outcome | 2026-07-06 | 2026-11-30 | — | — | certificate |
| 14 | The FDA accepts the NDA Filing for NDA Filing — neladalkib (NUVL) by 2026-11-27. | Awaiting outcome | 2026-07-06 | 2026-11-27 | — | — | certificate |
| 13 | FDA approves FDA PDUFA Date (priority review) (NUVL) on or before its PDUFA date 2026-11-27. | Awaiting outcome | 2026-07-06 | 2026-11-27 | — | — | certificate |
| 12 | FDA approves TLX250-CDx (TLPPF) on or before its PDUFA date 2026-11-15. | Awaiting outcome | 2026-07-06 | 2026-11-15 | — | — | certificate |
| 11 | FDA approves Drug: Ivonescimab Injection (SMMT) on or before its PDUFA date 2026-11-01. | Awaiting outcome | 2026-07-06 | 2026-11-01 | — | — | certificate |
| 10 | FDA approves Ziftomenib (KURA) on or before its PDUFA date 2026-10-22. | Awaiting outcome | 2026-07-06 | 2026-10-22 | — | — | certificate |
| 9 | The FDA accepts the NDA Filing for NDA Filing - MR-141 (VTRS) by 2026-10-17. | Awaiting outcome | 2026-07-06 | 2026-10-17 | — | — | certificate |
| 8 | XEN1101 (XENE) Phase 3 readout is positive by 2026-10-15. | Awaiting outcome | 2026-07-06 | 2026-10-15 | — | — | certificate |
| 7 | Dazucorilant 300 mg (CORT) Phase 2 readout is positive by 2026-10-15. | Awaiting outcome | 2026-07-06 | 2026-10-15 | — | — | certificate |
| 6 | TX000045- Dose A (TECX) Phase 2 readout is positive by 2026-10-09. | Awaiting outcome | 2026-07-06 | 2026-10-09 | — | — | certificate |
| 5 | Ruxolitinib Cream (INCY) Phase 3 readout is positive by 2026-10-09. | Awaiting outcome | 2026-07-06 | 2026-10-09 | — | — | certificate |
| 4 | FDA approves Atacicept (VERA) on or before its PDUFA date 2026-10-06. | Awaiting outcome | 2026-07-06 | 2026-10-06 | — | — | certificate |
| 3 | Physician's Choice medications (SOBI.ST) Phase 3 readout is positive by 2026-10-05. | Awaiting outcome | 2026-07-06 | 2026-10-05 | — | — | certificate |
| 2 | mRNA-1189 (MRNA) Phase 2 readout is positive by 2026-10-05. | Awaiting outcome | 2026-07-06 | 2026-10-05 | — | — | certificate |
| 1 | Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose (BNTX) Phase 3 readout is positive by 2026-07-23. | Awaiting outcome | 2026-07-06 | 2026-07-23 | — | — | certificate |
Cite this track record
A live badge for this stream — its own hit rate and anchor age, linking back to this verifiable track. Copy the HTML or Markdown.
